Highlights from 2024 World Conference on Lung Cancer
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Highlights from 2024 World Conference on Lung Cancer
-
Narrado por:
-
De:
Acerca de esta escucha
In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting.
Benjamin P. Levy, MD, discusses key takeaways from the meeting. 0:28
Read the full coverage here:
Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’
Source: Zhou C, et al. Abstract 2700. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego.
Perioperative nivolumab improves outcomes in resectable NSCLC
Source: Forde PM, et al. Abstract 3589. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego.
Despite progress, barriers to lung cancer biomarker testing persist
Source: Smeltzer M, et al. Abstract 3000. Presented at: IASLC World Conference on Lung Cancer; Sept. 7-10, 2024; San Diego.
Disclosures: Healio could not confirm relevant financial disclosures for Levy at the time of posting.